Cargando…
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214598/ https://www.ncbi.nlm.nih.gov/pubmed/30464486 http://dx.doi.org/10.2147/TCRM.S192185 |
Ejemplares similares
-
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2010) -
Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]
Publicado: (2022) -
Expression of Concern on “A Radiographic Study on the Associations of Age and Prevalence of Vertebral Fractures with Abdominal Aortic Calcification in Japanese Postmenopausal Women and Men”
por: Osteoporosis, Journal of
Publicado: (2022) -
Expression of Concern: Genetic Polymorphisms of Dihydropyrimidinase in a Japanese Patient with Capecitabine-Induced Toxicity
Publicado: (2023) -
Sexual behaviors among men who have sex with men: a quantitative cross
sectional study in Kathmandu Valley, Nepal [Expression of
concern]
Publicado: (2013)